Encountering objections and questions from payers and health technology assessment (HTA) decision-makers is an unavoidable part of bringing a new pharmaceutical or medical technology to market. Payer conversations provide an opportunity to acknowledge potential issues or evidence gaps and alleviate concerns.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile